For: |
Jin X, Kuang G, Wei LZ, Li Y, Wang R, Guo W, Wang N, Fang SM, Wen DG, Chen ZF, Zhang JH. No association of the |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i16/2385.htm |
Number | Citing Articles |
1 |
Zhongqiang Lu, Yanyan Cao, Yimin Wang, Qingjun Zhang, Xianghong Zhang, Shuheng Wang, Yuehong Li, Huiling Xie, Baohua Jiao, Jianhui Zhang. Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China. Journal of Neuro-Oncology 2007; 85(1): 65 doi: 10.1007/s11060-007-9392-5
|
2 |
E. Vairaktaris, C. Yapijakis, Z. Serefoglou, S. Derka, S. Vassiliou, E. Nkenke, A. Vylliotis, J. Wiltfang, D. Avgoustidis, E. Critselis, F.W. Neukam, E. Patsouris. The interleukin-8 (−251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. European Journal of Surgical Oncology (EJSO) 2007; 33(4): 504 doi: 10.1016/j.ejso.2006.11.002
|
3 |
Makoto Sugimoto, Shigeki Yoshida, Stephen Kennedy, Masashi Deguchi, Nyriyuki Ohara, Takeshi Maruo. Matrix Metalloproteinase-1 and -9 Promoter Polymorphisms and Endometrial Carcinoma Risk in a Japanese Population. Journal of the Society for Gynecologic Investigation 2006; 13(7): 523 doi: 10.1016/j.jsgi.2006.07.001
|
4 |
Xiaoying Li, Lianxi Qu, Yu Zhong, Yingjie Zhao, Hongyan Chen, Lu Daru. Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis. Journal of Cancer Research and Clinical Oncology 2013; 139(9): 1433 doi: 10.1007/s00432-013-1446-9
|
5 |
L. GAO, A. NIETERS, H. BRENNER. Meta‐analysis: tumour invasion‐related genetic polymorphisms and gastric cancer susceptibility. Alimentary Pharmacology & Therapeutics 2008; 28(5): 565 doi: 10.1111/j.1365-2036.2008.03760.x
|
6 |
Murat Altaş, Omer Faruk Bayrak, Erdogan Ayan, Fatihhan Bolukbası, Gokalp Sılav, Kerim Kenan Coskun, Mustafa Çulha, Fikrettin Sahin, Serhat Sevli, İlhan Elmacı. The effect of polymorphisms in the promoter region of the MMP-1 gene on the occurrence and invasiveness of hypophyseal adenoma. Acta Neurochirurgica 2010; 152(9): 1611 doi: 10.1007/s00701-010-0671-0
|
7 |
Yan Li, Dong-lan Sun, Ya-nan Duan, Xiao-juan Zhang, Na Wang, Rong-miao Zhou, Zhi-feng Chen, Shi-jie Wang. Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China. Molecular Biology Reports 2010; 37(1): 197 doi: 10.1007/s11033-009-9593-4
|
8 |
Bo Peng, Lihuan Cao, Wenzhang Wang, Lingling Xian, Deke Jiang, Jing Zhao, Zhen Zhang, Xiaoli Wang, Long Yu. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case–control studies. Mutagenesis 2010; 25(1): 41 doi: 10.1093/mutage/gep041
|
9 |
Hai Chen, Xianquan Xu, Congshu Hua, Heng Zhang, Junling Jian, Tengfei Ge, Jianfeng Xie, Zaicheng Yu. Polymorphisms of matrix metalloproteinases affect the susceptibility of esophageal cancer. Medicine 2021; 100(38): e27229 doi: 10.1097/MD.0000000000027229
|
10 |
Toru Hiyama, Masaharu Yoshihara, Shinji Tanaka, Kazuaki Chayama. Genetic polymorphisms and esophageal cancer risk. International Journal of Cancer 2007; 121(8): 1643 doi: 10.1002/ijc.23044
|
11 |
Erica Conway, Haisheng Wu, Linwei Tian. Overview of Risk Factors for Esophageal Squamous Cell Carcinoma in China. Cancers 2023; 15(23): 5604 doi: 10.3390/cancers15235604
|
12 |
Dan Liu, Hong Guo, Yafei Li, Xueqing Xu, Kang Yang, Yun Bai, Chunyan He. Association between Polymorphisms in the Promoter Regions of Matrix Metalloproteinases (MMPs) and Risk of Cancer Metastasis: A Meta-Analysis. PLoS ONE 2012; 7(2): e31251 doi: 10.1371/journal.pone.0031251
|
13 |
Jianhui Zhang, Xia Jin, Shumei Fang, Rui Wang, Yan Li, Na Wang, Wei Guo, Yimin Wang, Denggui Wen, Lizhen Wei, Zhiming Dong, Gang Kuang. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis 2005; 26(10): 1748 doi: 10.1093/carcin/bgi144
|
14 |
Jacqueline Miranda de Lima, Lessileia Gomes de Souza, Ismael Dale Cotrim Guerreiro da Silva, Nora Manoukian Forones. E-Cadherin and Metalloproteinase-1 and -7 Polymorphisms in Colorectal Cancer. The International Journal of Biological Markers 2009; 24(2): 99 doi: 10.1177/172460080902400206
|
15 |
Yong-Xi Song, Xin Zhou, Zhen-Ning Wang, Peng Gao, Ai-Lin Li, Ji-Wang Liang, Jin-Liang Zhu, Ying-Ying Xu, Hui-Mian Xu, Yury E. Khudyakov. The Association between Individual SNPs or Haplotypes of Matrix Metalloproteinase 1 and Gastric Cancer Susceptibility, Progression and Prognosis. PLoS ONE 2012; 7(5): e38002 doi: 10.1371/journal.pone.0038002
|
16 |
Teng-Fei Yang, Lin Guo, Qiang Wang. Meta-analysis of Associations Between four Polymorphisms in the Matrix Metalloproteinases Gene and Gastric Cancer Risk. Asian Pacific Journal of Cancer Prevention 2014; 15(3): 1263 doi: 10.7314/APJCP.2014.15.3.1263
|
17 |
Alexandra MJ Langers, Hein W Verspaget, Daniel W Hommes, Cornelis FM Sier. Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer. World Journal of Gastrointestinal Oncology 2011; 3(6): 79-98 doi: 10.4251/wjgo.v3.i6.79
|
18 |
Irene Tramacere, Carlo La Vecchia, Eva Negri. Tobacco Smoking and Esophageal and Gastric Cardia Adenocarcinoma. Epidemiology 2011; 22(3): 344 doi: 10.1097/EDE.0b013e31821092cd
|
19 |
Jun Sui, Jing Huang, YongChen Zhang. The MMP-1 Gene rs1799750 Polymorphism Is Associated with Breast Cancer Risk. Genetic Testing and Molecular Biomarkers 2021; 25(7): 496 doi: 10.1089/gtmb.2021.0016
|
20 |
Mei-Due Yang, Kuo-Cheng Lin, Meng-Chun Lu, Long-Bin Jeng, Chieh-Lun Hsiao, Te-Cheng Yueh, Chun-Kai Fu, Hsin-Ting Li, Shiou-Ting Yen, Chia-Wen Lin, Cin-Wun Wu, Su-Yi Pang, Da-Tian Bau, Fuu-Jen Tsai. Contribution of matrix metalloproteinases-1 genotypes to gastric cancer susceptibility in Taiwan. BioMedicine 2017; 7(2): 10 doi: 10.1051/bmdcn/2017070203
|
21 |
He Dedong, Zhang Bin, Sun Peisheng, Xu Hongwei, Yang Qinghui. The Contribution of the Genetic Variations of the Matrix Metalloproteinase-1 Gene to the Genetic Susceptibility of Gastric Cancer. Genetic Testing and Molecular Biomarkers 2014; 18(10): 675 doi: 10.1089/gtmb.2014.0117
|
22 |
Li-E Wang, Yu-jing Huang, Ming Yin, Jeffrey E. Gershenwald, Victor G. Prieto, Jeffrey E. Lee, Madeleine Duvic, Elizabeth A. Grimm, Qingyi Wei. Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma. European Journal of Cancer 2011; 47(1): 107 doi: 10.1016/j.ejca.2010.06.129
|
23 |
Jin Wu. Matrix Metalloproteinase 1, 3, and 9 Polymorphisms and Esophageal Squamous Cell Carcinoma Risk. Medical Science Monitor 2014; 20: 2269 doi: 10.12659/MSM.892413
|
24 |
Zhonghan Zhou, Xiaocheng Ma, Fangming Wang, Lijiang Sun, Guiming Zhang. A Matrix Metalloproteinase-1 Polymorphism,MMP1–1607(1G>2G), Is Associated with Increased Cancer Risk: A Meta-Analysis Including 21,327 Patients. Disease Markers 2018; 2018: 1 doi: 10.1155/2018/7565834
|
25 |
Sanjib Dey, Nillu Ghosh, Debjit Saha, Kousik Kesh, Arnab Gupta, Snehasikta Swarnakar, Redhwan Ahmed Al Naggar. Matrix Metalloproteinase-1 (MMP-1) Promoter Polymorphisms are Well Linked with Lower Stomach Tumor Formation in Eastern Indian Population. PLoS ONE 2014; 9(2): e88040 doi: 10.1371/journal.pone.0088040
|